» Articles » PMID: 23745564

Molecular Imaging Strategies for in Vivo Tracking of MicroRNAs: a Comprehensive Review

Overview
Journal Curr Med Chem
Specialty Chemistry
Date 2013 Jun 11
PMID 23745564
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are single-stranded non-coding RNAs of ~22 nucleotides, which can negatively regulate gene expression through induction of mRNA degradation and/or post-transcriptional gene silencing. MiRNAs are key factors in the regulation of many biological processes such as cell proliferation, differentiation, and death. Since miRNAs are known to be in close association with cancer development, non-invasive imaging of miRNA expression and/or activity is of critical importance, for which conventional molecular biology techniques are not suitable or applicable. Over the last several years, various molecular imaging techniques have been investigated for imaging of miRNAs. In this review article, we summarize the current state-of-the-art imaging of miRNAs, which are typically based on fluorescent proteins, bioluminescent enzymes, molecular beacons, and/or various nanoparticles. Non-invasive imaging of miRNA expression and/or biological activity is still at its infancy. Future research on more clinically relevant, non-toxic techniques is required to move the field of miRNA imaging into clinical applications. Non-invasive imaging of miRNA is an invaluable method that can not only significantly advance our understandings of a wide range of human diseases, but also lead to new and more effective treatment strategies for these diseases.

Citing Articles

Circulating miR-126-3p is a mechanistic biomarker for knee osteoarthritis.

Wilson T, Baghel M, Kaur N, Datta I, Loveless I, Potla P Nat Commun. 2025; 16(1):2021.

PMID: 40016267 PMC: 11868599. DOI: 10.1038/s41467-025-57308-5.


A novel tetrapeptide for chelator-free radiolabeling in optimized preparation of Tc-radiolabeled oligonucleotides.

Chen Z, Yang Q, Song L, Qiu Y, Wu S, Huang W Am J Nucl Med Mol Imaging. 2022; 12(5):143-151.

PMID: 36419586 PMC: 9677136.


miRNA Delivery by Nanosystems: State of the Art and Perspectives.

Moraes F, Pichon C, Letourneur D, Chaubet F Pharmaceutics. 2021; 13(11).

PMID: 34834316 PMC: 8619868. DOI: 10.3390/pharmaceutics13111901.


Polariton-assisted manipulation of energy relaxation pathways: donor-acceptor role reversal in a tuneable microcavity.

Dovzhenko D, Lednev M, Mochalov K, Vaskan I, Rakovich Y, Karaulov A Chem Sci. 2021; 12(38):12794-12805.

PMID: 34703566 PMC: 8494027. DOI: 10.1039/d1sc02026a.


LentiRILES, a miRNA-ON sensor system for monitoring the functionality of miRNA in cancer biology and therapy.

Simion V, Loussouarn C, Laurent Y, Roncali L, Gosset D, Reverchon F RNA Biol. 2021; 18(sup1):198-214.

PMID: 34570661 PMC: 8682973. DOI: 10.1080/15476286.2021.1978202.


References
1.
Lin S, Johnson S, Abraham M, Vella M, Pasquinelli A, Gamberi C . The C elegans hunchback homolog, hbl-1, controls temporal patterning and is a probable microRNA target. Dev Cell. 2003; 4(5):639-50. DOI: 10.1016/s1534-5807(03)00124-2. View

2.
Ko M, Kim S, Hwang D, Ko H, Kim Y, Lee D . Bioimaging of the unbalanced expression of microRNA9 and microRNA9* during the neuronal differentiation of P19 cells. FEBS J. 2008; 275(10):2605-16. DOI: 10.1111/j.1742-4658.2008.06408.x. View

3.
Yao Q, Zhang A, Ma H, Lin S, Wang X, Sun J . Novel molecular beacons to monitor microRNAs in non-small-cell lung cancer. Mol Cell Probes. 2012; 26(5):182-7. DOI: 10.1016/j.mcp.2012.07.001. View

4.
Kim V, Nam J . Genomics of microRNA. Trends Genet. 2006; 22(3):165-73. DOI: 10.1016/j.tig.2006.01.003. View

5.
Ma L, Teruya-Feldstein J, Weinberg R . Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature. 2007; 449(7163):682-8. DOI: 10.1038/nature06174. View